Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a medical technology company that designs, manufactures, and markets silicone-filled breast and body-shaping implants. Its revenue growth, driven by strong sales in the U.S. and progress towards profitability, is expected to reach $35M this year. The company has surpassed 1,700 U.S. accounts and is seeing a shift in behavior among higher-volume surgeons, resulting in a 30% increase in average orders. With its unique product and potential for expansion into new markets, this company has strong potential for long-term success.

Bears say

Establishment Labs Hldgs is expected to have a strong revenue growth trajectory, with guidance for the full year 2026 forecasted to increase by 26-27% year-over-year and US revenue expected to exceed 30% of overall sales. However, the company's reliance on a single product, Motiva implants, and its high valuation compared to industry peers may pose risks for potential investors. Additionally, the company's positive outlook for free cash flow in 2026 may be impacted by unexpected market conditions.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.